Uveitis Trial, Not Yet Recruiting NCT06920017 Sponsor: Assiut University Condition: Uveitis
Back to Uveitis

Uveitis Trial, Not Yet Recruiting

NCT06920017
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are under 18 years old and have been diagnosed with uveitis (inflammation inside the eye)
  • You are able to take part in the study activities

Who may not be able to join:

  • You are 18 years old or older
  • You have had a serious penetrating injury to the eye in the past
  • Your parent or legal guardian is not willing to give permission for you to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohamed Sharaf El Din Abd El Rahim, professor, Assiut University

Phone: +201090793398

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 April 2026

Primary endpoints

Distribution of uveitis subtypes.; Differences by age, gender, or ethnicity.; Prevalence of systemic associations.; Prevalence of Visual outcomes.; Prevalence of complications rate.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov